Please enable JavaScript to continue using this application.

Compare $ARMP vs $TNXP | Chartloom

Compare

$ARMP vs $TNXP

Armata Pharmaceuticals Inc · Tonix Pharmaceuticals Holding Corp

ARMP

Armata Pharmaceuticals Inc

TNXP

Tonix Pharmaceuticals Holding Corp

Compare $ARMP vs $TNXP

Comparing Armata Pharmaceuticals Inc and Tonix Pharmaceuticals Holding Corp

ARMPArmata Pharmaceuticals Inc

TNXPTonix Pharmaceuticals Holding Corp

ARMPArmata Pharmaceuticals Inc

Market cap

$133M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-19.3%

YTD performance

-44.7%

52W performance

12.7%

FCF yield

-19.4%

TNXPTonix Pharmaceuticals Holding Corp

Market cap

$116M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

1.39x

Rev growth (TTM)

196.0%

YTD performance

-55.9%

52W performance

-67.5%

FCF yield

-135.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ARMP

TNXP

Detailed metrics comparison

ARMP

Armata Pharmaceuticals Inc

TNXP

Tonix Pharmaceuticals Holding Corp

Market Cap

ARMP$133M

TNXP$116M

Enterprise Value

ARMP$393M

TNXP$-60M

Price

ARMP$3.63

TNXP$7.30

P/E Ratio

ARMPN/A

TNXPN/A

P/S Ratio

ARMP24.04x

TNXP4.00x

EV/Sales

ARMP70.87x

TNXP-2.06x

EV/EBITDA

ARMP0.00x

TNXP0.00x

P/B Ratio

ARMP6.85x

TNXP0.69x

P/FCF Ratio

ARMPN/A

TNXPN/A

EV/FCF

ARMP-15.23x

TNXP0.38x

PEG Ratio

ARMPN/A

TNXPN/A

Forward P/E (NTM)

ARMPN/A

TNXPN/A

Forward P/S (NTM)

ARMPN/A

TNXP1.39x

Revenue (TTM)

ARMP$6M

TNXP$29M

Revenue Growth (YoY)

ARMP-19.3%

TNXP196.0%

Forward Rev Growth

ARMP-35.3%

TNXP101.6%

Gross Margin (TTM)

ARMP0.0%

TNXP83.8%

Operating Margin (TTM)

ARMP0.0%

TNXP0.0%

EBITDA Margin (TTM)

ARMP-603.4%

TNXP-561.1%

Net Margin (TTM)

ARMP-3467.0%

TNXP-548.6%

FCF Margin (TTM)

ARMP-465.3%

TNXP-543.3%

Net Income (TTM)

ARMP$-192M

TNXP$-160M

FCF (TTM)

ARMP$-26M

TNXP$-158M

EPS (TTM)

ARMP-$3.10

TNXP-$9.60

ROE (TTM)

ARMP-12000.0%

TNXP-6899.0%

ROA (TTM)

ARMP-23569.0%

TNXP-6132.0%

ROIC (TTM)

ARMP-8123.0%

TNXP-6899.0%

Cash

ARMP$24M

TNXP$176M

Debt

ARMP$284M

TNXP$0

Net Cash/Debt

ARMP$-260M

TNXP$176M

Current Ratio (TTM)

ARMP0.11x

TNXP6.61x

Quick Ratio (TTM)

ARMP0.11x

TNXP6.13x

Debt/Equity (TTM)

ARMP1.38x

TNXP0.00x

Debt/Assets (TTM)

ARMP0.0%

TNXP0.0%

Interest Coverage (TTM)

ARMPN/A

TNXPN/A

Net Debt/EBITDA (TTM)

ARMP0.00x

TNXP0.00x

Beta

ARMP1.66

TNXP1.87

52W Performance

ARMP12.7%

TNXP-67.5%

YTD Performance

ARMP-44.7%

TNXP-55.9%

% from 52W High

ARMP-77.8%

TNXP-68.3%

% from 52W Low

ARMP17.5%

TNXP3.0%

Asset Turnover (TTM)

ARMP0.07x

TNXP0.11x

FCF Yield (TTM)

ARMP-19.4%

TNXP-135.9%

Earnings Yield (TTM)

ARMP-144.2%

TNXP-137.2%

Dividend Yield (TTM)

ARMPN/A

TNXPN/A

Rule of 40

ARMP-484.6

TNXP-347.3

EV/GP/RG

ARMPN/A

TNXPN/A

Ticker research

View ARMP research View TNXP research

Metric	ARMP Armata Pharmaceuticals Inc	TNXP Tonix Pharmaceuticals Holding Corp
Market & Valuation
Market Cap	$133M	$116M
Enterprise Value	$393M	$-60M
Price	$3.63	$7.30
P/E Ratio	N/A	N/A
P/S Ratio	24.04x	4.00x
EV/Sales	70.87x	-2.06x
EV/EBITDA	0.00x	0.00x
P/B Ratio	6.85x	0.69x
P/FCF Ratio	N/A	N/A
EV/FCF	-15.23x	0.38x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	1.39x
Revenue & Growth
Revenue (TTM)	$6M	$29M
Revenue Growth (YoY)	-19.3%	196.0%
Forward Rev Growth	-35.3%	101.6%
Profitability
Gross Margin (TTM)	0.0%	83.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-603.4%	-561.1%
Net Margin (TTM)	-3467.0%	-548.6%
FCF Margin (TTM)	-465.3%	-543.3%
Net Income (TTM)	$-192M	$-160M
FCF (TTM)	$-26M	$-158M
EPS (TTM)	-$3.10	-$9.60
ROE (TTM)	-12000.0%	-6899.0%
ROA (TTM)	-23569.0%	-6132.0%
ROIC (TTM)	-8123.0%	-6899.0%
Financial Health
Cash	$24M	$176M
Debt	$284M	$0
Net Cash/Debt	$-260M	$176M
Current Ratio (TTM)	0.11x	6.61x
Quick Ratio (TTM)	0.11x	6.13x
Debt/Equity (TTM)	1.38x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.66	1.87
52W Performance	12.7%	-67.5%
YTD Performance	-44.7%	-55.9%
% from 52W High	-77.8%	-68.3%
% from 52W Low	17.5%	3.0%
Efficiency & Yields
Asset Turnover (TTM)	0.07x	0.11x
FCF Yield (TTM)	-19.4%	-135.9%
Earnings Yield (TTM)	-144.2%	-137.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-484.6	-347.3
EV/GP/RG	N/A	N/A
Ticker research	View ARMP research	View TNXP research

Valuation

P/S Ratio

TNXP

4.00x

ARMP

24.04x

EV/FCF

ARMP

-15.23x

TNXP

0.38x

Growth & revenue

Revenue Growth TTM

TNXP

196.0%

ARMP

-19.3%

Forward Revenue Growth

TNXP

101.6%

ARMP

-35.3%

Profitability & performance

Gross Margin

TNXP

83.8%

ARMP

0.0%

ROE

TNXP

-6899.0%

ARMP

-12000.0%

FCF Yield %

ARMP

-19.4%

TNXP

-135.9%

52-Week Performance

ARMP

12.7%

TNXP

-67.5%

Detailed metrics comparison

ARMP

Armata Pharmaceuticals Inc

TNXP

Tonix Pharmaceuticals Holding Corp

Market Cap

ARMP$133M

TNXP$116M

Enterprise Value

ARMP$393M

TNXP$-60M

Price

ARMP$3.63

TNXP$7.30

P/E Ratio

ARMPN/A

TNXPN/A

P/S Ratio

ARMP24.04x

TNXP4.00x

EV/Sales

ARMP70.87x

TNXP-2.06x

EV/EBITDA

ARMP0.00x

TNXP0.00x

P/B Ratio

ARMP6.85x

TNXP0.69x

P/FCF Ratio

ARMPN/A

TNXPN/A

EV/FCF

ARMP-15.23x

TNXP0.38x

PEG Ratio

ARMPN/A

TNXPN/A

Forward P/E (NTM)

ARMPN/A

TNXPN/A

Forward P/S (NTM)

ARMPN/A

TNXP1.39x

Revenue (TTM)

ARMP$6M

TNXP$29M

Revenue Growth (YoY)

ARMP-19.3%

TNXP196.0%

Forward Rev Growth

ARMP-35.3%

TNXP101.6%

Gross Margin (TTM)

ARMP0.0%

TNXP83.8%

Operating Margin (TTM)

ARMP0.0%

TNXP0.0%

EBITDA Margin (TTM)

ARMP-603.4%

TNXP-561.1%

Net Margin (TTM)

ARMP-3467.0%

TNXP-548.6%

FCF Margin (TTM)

ARMP-465.3%

TNXP-543.3%

Net Income (TTM)

ARMP$-192M

TNXP$-160M

FCF (TTM)

ARMP$-26M

TNXP$-158M

EPS (TTM)

ARMP-$3.10

TNXP-$9.60

ROE (TTM)

ARMP-12000.0%

TNXP-6899.0%

ROA (TTM)

ARMP-23569.0%

TNXP-6132.0%

ROIC (TTM)

ARMP-8123.0%

TNXP-6899.0%

Cash

ARMP$24M

TNXP$176M

Debt

ARMP$284M

TNXP$0

Net Cash/Debt

ARMP$-260M

TNXP$176M

Current Ratio (TTM)

ARMP0.11x

TNXP6.61x

Quick Ratio (TTM)

ARMP0.11x

TNXP6.13x

Debt/Equity (TTM)

ARMP1.38x

TNXP0.00x

Debt/Assets (TTM)

ARMP0.0%

TNXP0.0%

Interest Coverage (TTM)

ARMPN/A

TNXPN/A

Net Debt/EBITDA (TTM)

ARMP0.00x

TNXP0.00x

Beta

ARMP1.66

TNXP1.87

52W Performance

ARMP12.7%

TNXP-67.5%

YTD Performance

ARMP-44.7%

TNXP-55.9%

% from 52W High

ARMP-77.8%

TNXP-68.3%

% from 52W Low

ARMP17.5%

TNXP3.0%

Asset Turnover (TTM)

ARMP0.07x

TNXP0.11x

FCF Yield (TTM)

ARMP-19.4%

TNXP-135.9%

Earnings Yield (TTM)

ARMP-144.2%

TNXP-137.2%

Dividend Yield (TTM)

ARMPN/A

TNXPN/A

Rule of 40

ARMP-484.6

TNXP-347.3

EV/GP/RG

ARMPN/A

TNXPN/A

Ticker research

View ARMP research View TNXP research

Metric	ARMP Armata Pharmaceuticals Inc	TNXP Tonix Pharmaceuticals Holding Corp
Market & Valuation
Market Cap	$133M	$116M
Enterprise Value	$393M	$-60M
Price	$3.63	$7.30
P/E Ratio	N/A	N/A
P/S Ratio	24.04x	4.00x
EV/Sales	70.87x	-2.06x
EV/EBITDA	0.00x	0.00x
P/B Ratio	6.85x	0.69x
P/FCF Ratio	N/A	N/A
EV/FCF	-15.23x	0.38x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	1.39x
Revenue & Growth
Revenue (TTM)	$6M	$29M
Revenue Growth (YoY)	-19.3%	196.0%
Forward Rev Growth	-35.3%	101.6%
Profitability
Gross Margin (TTM)	0.0%	83.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-603.4%	-561.1%
Net Margin (TTM)	-3467.0%	-548.6%
FCF Margin (TTM)	-465.3%	-543.3%
Net Income (TTM)	$-192M	$-160M
FCF (TTM)	$-26M	$-158M
EPS (TTM)	-$3.10	-$9.60
ROE (TTM)	-12000.0%	-6899.0%
ROA (TTM)	-23569.0%	-6132.0%
ROIC (TTM)	-8123.0%	-6899.0%
Financial Health
Cash	$24M	$176M
Debt	$284M	$0
Net Cash/Debt	$-260M	$176M
Current Ratio (TTM)	0.11x	6.61x
Quick Ratio (TTM)	0.11x	6.13x
Debt/Equity (TTM)	1.38x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.66	1.87
52W Performance	12.7%	-67.5%
YTD Performance	-44.7%	-55.9%
% from 52W High	-77.8%	-68.3%
% from 52W Low	17.5%	3.0%
Efficiency & Yields
Asset Turnover (TTM)	0.07x	0.11x
FCF Yield (TTM)	-19.4%	-135.9%
Earnings Yield (TTM)	-144.2%	-137.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-484.6	-347.3
EV/GP/RG	N/A	N/A
Ticker research	View ARMP research	View TNXP research